Dernières nouvelles
Information non disponible
Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
Article de revueJ Nucl Med, 2024.
Outcomes of adults with refractory or relapsed acute myeloid leukemia treated with azacitidine and venetoclax compared to other therapies: a multicenter retrospective study
Article de revueLeuk Lymphoma, 2024.
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study
Article de revueCancer Med, 12 (18), 2023.
The ever wider clinical spectrum of RMND1-related disorders and limitedness of phenotype-based classifications
Article de revueJ Mol Med (Berl), 101 (10), 2023.
Pembrolizumab-Induced Anti-GBM Glomerulonephritis: A Case Report
Article de revueKidney Med, 5 (8), 2023.